Smoking is associated with more serious forms of pulmonary sarcoidosis

D. Ionita, C. Cilt, N. Bisca, I. Balcu, D. Marta, R. Nemes, A. Macri, I. Strambu, C. Tudose, C. Toma, A. Serbescu, L. Cervis, I. P. Stoicescu (Bucharest, Romania)

Source: Annual Congress 2006 - Sarcoidosis
Session: Sarcoidosis
Session type: Electronic Poster Discussion
Number: 3140
Disease area: Interstitial lung diseases

Congress or journal article abstract

Abstract

Objective: To investigate the frequency of smoking and its association with clinical or paraclinical data, in newly diagnosed pulmonary sarcoidosis.
Subjects and methods: 317 patients (age 38.4±11.7, 194 women) were prospectively investigated in 1998-2004 in our Institute, with chest X-ray, pulmonary function tests (volumes, flows, diffusion), serum angiotensin-converting enzyme (ACE), fiber-bronchoscopy with broncho-alveolar lavage (BAL).
Results: 82 patients (25.9%) were (ex)smokers. There were no differences between smokers and nonsmokers, by age, diagnosis delay or type of onset (p=NS). (Ex)smokers had significantly lower lung volumes (p=0.003), flows (p=0.001), and diffusion capacity (p=0.008), more BAL neutrophylls (p=0.009) and macrophages (p=0.015), less BAL lymphocytes (p=0.002), higher ACE values (p=0.001), and more parenchymal involvement on chest X-ray – stages II or III (p=0.001). Bronchial obstruction (recorded in 43 patients, 13.6%) was not associated with smoking (p=NS). Higher pack-year history (over 10) was associated with dyspnoea (p=0.003) and higher diagnostic delay (p=0.019).
Conclusion: Smoking in patients with newly diagnosed sarcoidosis was associated with a more serious condition: lower pulmonary function tests data, frequent interstitial involvement, higher BAL neutrophylls, but not with bronchial obstruction. Heavy smoking may delay the diagnosis of sarcoidosis by obscuring associated symptoms.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Ionita, C. Cilt, N. Bisca, I. Balcu, D. Marta, R. Nemes, A. Macri, I. Strambu, C. Tudose, C. Toma, A. Serbescu, L. Cervis, I. P. Stoicescu (Bucharest, Romania). Smoking is associated with more serious forms of pulmonary sarcoidosis. Eur Respir J 2006; 28: Suppl. 50, 3140

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cigarette smoking contributes to idiopathic pulmonary fibrosis associated with emphysema
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010

Associations between emphysema and pulmonary fibrosis are suggestive of a smoking pathogenesis common to both disorders
Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis
Year: 2008


Pulmonary hypertension associated with sarcoidosis
Source: Eur Respir Mon 2012; 57: 166-181
Year: 2012


Prevalence of active smokers among 49 patients affected by interstial lung diseases at two referral centers
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Pulmonary hypertension in chronic obstructive pulmonary disease: the role of cigarette smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
Source: Eur Respir J 2010; 35: 105-111
Year: 2010



Systemic manifestations in smokers and mild/moderate chronic obstructive pulmonary disease
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015

Prevalence of smoking among Polish sarcoid patients
Source: International Congress 2016 – Sarcoidosis
Year: 2016

Smoking behaviour profile in pulmonary tuberculosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 20s
Year: 2006

Never-smoking history as a poor prognostic factor in surgically proven idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013


Pulmonary hypertension associated with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 656s
Year: 2006

Biomarkers in pulmonary hypertension associated to interstitial lung disease
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Smoking patterns in patients following a pulmonary embolism
Source: Eur Respir J 2009; 33: 942-943
Year: 2009


Tobacco smoke in patients with pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Pulmonary fibrosis is associated with emphysema in systemic sclerosis: indirect support for a smoking pathogenesis hypothesis
Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms
Year: 2009

History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012



Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012



Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis
Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020
Year: 2021



Smoking, systemic inflammation and pulmonary function
Source: Eur Respir J 2006; 28: Suppl. 50, 248s
Year: 2006